Global Fludeoxyglucose F 18 Injection Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fludeoxyglucose F 18 Injection Market Insights, Forecast to 2034
Fludeoxyglucose F 18 Injection is used for positron emission tomography (PET), and uses the characteristics of abnormal glucose metabolism of lesions for localization diagnosis and evaluation. 1. Used for tumor PET imaging to evaluate the malignancy of suspected or confirmed cases. 2. Used for PET imaging of coronary artery disease and left ventricular dysfunction. Combined with other myocardial perfusion imaging, it is used to evaluate the myocardial activity of the left ventricle and the recoverability of myocardial systolic function in cases of left ventricular dysfunction. 3. It is used to determine the epilepsy focus in epilepsy patients related to abnormal glucose metabolism.
Global Fludeoxyglucose F 18 Injection market is expected to reach to US$ 117 million in 2024, with a positive growth of %, compared with US$ 109 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Fludeoxyglucose F 18 Injection industry is evaluated to reach US$ 177.6 million in 2029. The CAGR will be 7.2% during 2024 to 2029.
Fludeoxyglucose F 18 Injection is currently the most widely used positron radioactive drug in clinical practice.
Report Covers
This report presents an overview of global Fludeoxyglucose F 18 Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Fludeoxyglucose F 18 Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.,Ltd.
Hta Co., Ltd
Guangdong Cyclotron Medical Science Co., Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
China Isotope & Radiation Corporation
Segment by Type
<200 mCi/1mL
200-300 mCi/1mL
>300 mCi/1mL
Cancer
Heart Disease
Epilepsy
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Fludeoxyglucose F 18 Injection plant distribution, commercial date of Fludeoxyglucose F 18 Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Fludeoxyglucose F 18 Injection introduction, etc. Fludeoxyglucose F 18 Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Fludeoxyglucose F 18 Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Fludeoxyglucose F 18 Injection market is expected to reach to US$ 117 million in 2024, with a positive growth of %, compared with US$ 109 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Fludeoxyglucose F 18 Injection industry is evaluated to reach US$ 177.6 million in 2029. The CAGR will be 7.2% during 2024 to 2029.
Fludeoxyglucose F 18 Injection is currently the most widely used positron radioactive drug in clinical practice.
Report Covers
This report presents an overview of global Fludeoxyglucose F 18 Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Fludeoxyglucose F 18 Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.,Ltd.
Hta Co., Ltd
Guangdong Cyclotron Medical Science Co., Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
China Isotope & Radiation Corporation
Segment by Type
<200 mCi/1mL
200-300 mCi/1mL
>300 mCi/1mL
Segment by Application
Cancer
Heart Disease
Epilepsy
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Fludeoxyglucose F 18 Injection plant distribution, commercial date of Fludeoxyglucose F 18 Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Fludeoxyglucose F 18 Injection introduction, etc. Fludeoxyglucose F 18 Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Fludeoxyglucose F 18 Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports